Literature DB >> 22221116

Progressive conduction defects and cardiac death in late infantile neuronal ceroid lipofuscinosis.

Shinobu Fukumura1, Yoshiaki Saito, Takashi Saito, Hirofumi Komaki, Eiji Nakagawa, Kenji Sugai, Masayuki Sasaki, Akira Oka, Itaru Takamisawa.   

Abstract

This article reports the case of a female with late infantile neuronal ceroid lipofuscinosis who developed right and left anterior bundle branch blocks and episodic bradycardia at 23 years of age. Several episodes of supraventricular tachycardia manifested at 23 and 27 years of age. In addition, a transient second-degree atrioventricular conduction block also emerged at 27 years of age. Atrial fibrillation and aggravation of the atrioventricular conduction block resulted in progressive bradycardia and cardiac death at the age of 28 years. Cardiac involvement and accumulation of lipopigments in the myocardium and cardiac conduction system have been recognized in juvenile neuronal ceroid lipofuscinosis, but this is the first report to describe progressive conduction defects in a case of late infantile neuronal ceroid lipofuscinosis. © The Authors. Developmental Medicine & Child Neurology
© 2011 Mac Keith Press.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22221116     DOI: 10.1111/j.1469-8749.2011.04170.x

Source DB:  PubMed          Journal:  Dev Med Child Neurol        ISSN: 0012-1622            Impact factor:   5.449


  12 in total

Review 1.  Vision loss in juvenile neuronal ceroid lipofuscinosis (CLN3 disease).

Authors:  Madhu M Ouseph; Mark E Kleinman; Qing Jun Wang
Journal:  Ann N Y Acad Sci       Date:  2016-01-08       Impact factor: 5.691

Review 2.  Neuronal ceroid lipofuscinosis: impact of recent genetic advances and expansion of the clinicopathologic spectrum.

Authors:  Susan L Cotman; Amel Karaa; John F Staropoli; Katherine B Sims
Journal:  Curr Neurol Neurosci Rep       Date:  2013-08       Impact factor: 5.081

3.  AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease.

Authors:  Martin L Katz; Luis Tecedor; Yonghong Chen; Baye G Williamson; Elena Lysenko; Fred A Wininger; Whitney M Young; Gayle C Johnson; Rebecca E H Whiting; Joan R Coates; Beverly L Davidson
Journal:  Sci Transl Med       Date:  2015-11-11       Impact factor: 17.956

4.  Synergistic effects of treating the spinal cord and brain in CLN1 disease.

Authors:  Charles Shyng; Hemanth R Nelvagal; Joshua T Dearborn; Jaana Tyynelä; Robert E Schmidt; Mark S Sands; Jonathan D Cooper
Journal:  Proc Natl Acad Sci U S A       Date:  2017-07-03       Impact factor: 11.205

5.  Early infantile neuronal ceroid lipofuscinosis (CLN10 disease) associated with a novel mutation in CTSD.

Authors:  Stefano Doccini; Stefano Sartori; Stefan Maeser; Francesco Pezzini; Sara Rossato; Francesca Moro; Irene Toldo; Michael Przybylski; Filippo M Santorelli; Alessandro Simonati
Journal:  J Neurol       Date:  2016-04-12       Impact factor: 4.849

6.  Extraneuronal pathology in a canine model of CLN2 neuronal ceroid lipofuscinosis after intracerebroventricular gene therapy that delays neurological disease progression.

Authors:  M L Katz; G C Johnson; S B Leach; B G Williamson; J R Coates; R E H Whiting; D P Vansteenkiste; M S Whitney
Journal:  Gene Ther       Date:  2017-02-02       Impact factor: 5.250

7.  Urine proteomics analysis of patients with neuronal ceroid lipofuscinoses.

Authors:  Katharina Iwan; Robert Clayton; Philippa Mills; Barbara Csanyi; Paul Gissen; Sara E Mole; David N Palmer; Kevin Mills; Wendy E Heywood
Journal:  iScience       Date:  2020-12-31

8.  Guidelines on the diagnosis, clinical assessments, treatment and management for CLN2 disease patients.

Authors:  Sara E Mole; Angela Schulz; Eben Badoe; Samuel F Berkovic; Emily C de Los Reyes; Simon Dulz; Paul Gissen; Norberto Guelbert; Charles M Lourenco; Heather L Mason; Jonathan W Mink; Noreen Murphy; Miriam Nickel; Joffre E Olaya; Maurizio Scarpa; Ingrid E Scheffer; Alessandro Simonati; Nicola Specchio; Ina Von Löbbecke; Raymond Y Wang; Ruth E Williams
Journal:  Orphanet J Rare Dis       Date:  2021-04-21       Impact factor: 4.123

9.  Altered biometal homeostasis is associated with CLN6 mRNA loss in mouse neuronal ceroid lipofuscinosis.

Authors:  Katja M Kanninen; Alexandra Grubman; Aphrodite Caragounis; Clare Duncan; Sarah J Parker; Grace E Lidgerwood; Irene Volitakis; George Ganio; Peter J Crouch; Anthony R White
Journal:  Biol Open       Date:  2013-05-20       Impact factor: 2.422

10.  Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease).

Authors:  Martin L Katz; Joan R Coates; Christine M Sibigtroth; Jacob D Taylor; Melissa Carpentier; Whitney M Young; Fred A Wininger; Derek Kennedy; Brian R Vuillemenot; Charles A O'Neill
Journal:  J Neurosci Res       Date:  2014-06-17       Impact factor: 4.164

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.